Structure

Physi-Chem Properties

Molecular Weight:  594.16
Volume:  543.527
LogP:  0.345
LogD:  -0.15
LogS:  -3.394
# Rotatable Bonds:  6
TPSA:  249.2
# H-Bond Aceptor:  15
# H-Bond Donor:  9
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.159
Synthetic Accessibility Score:  4.671
Fsp3:  0.444
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.487
MDCK Permeability:  2.347303416172508e-05
Pgp-inhibitor:  0.003
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.829
20% Bioavailability (F20%):  0.009
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.044
Plasma Protein Binding (PPB):  88.45126342773438%
Volume Distribution (VD):  0.775
Pgp-substrate:  9.529308319091797%

ADMET: Metabolism

CYP1A2-inhibitor:  0.145
CYP1A2-substrate:  0.039
CYP2C19-inhibitor:  0.049
CYP2C19-substrate:  0.054
CYP2C9-inhibitor:  0.015
CYP2C9-substrate:  0.118
CYP2D6-inhibitor:  0.07
CYP2D6-substrate:  0.131
CYP3A4-inhibitor:  0.049
CYP3A4-substrate:  0.004

ADMET: Excretion

Clearance (CL):  1.282
Half-life (T1/2):  0.645

ADMET: Toxicity

hERG Blockers:  0.241
Human Hepatotoxicity (H-HT):  0.07
Drug-inuced Liver Injury (DILI):  0.983
AMES Toxicity:  0.833
Rat Oral Acute Toxicity:  0.034
Maximum Recommended Daily Dose:  0.004
Skin Sensitization:  0.87
Carcinogencity:  0.179
Eye Corrosion:  0.003
Eye Irritation:  0.124
Respiratory Toxicity:  0.033

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC187379

Natural Product ID:  NPC187379
Common Name*:   Kaempferol 4'-O-Alpha-L-Rhamnopyranosyl-(1->6)-Beta-D-Glucopyranoside
IUPAC Name:   3,5,7-trihydroxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]chromen-4-one
Synonyms:  
Standard InCHIKey:  NTBNRFPZTCXMTF-QETNVOEASA-N
Standard InCHI:  InChI=1S/C27H30O15/c1-9-17(30)20(33)23(36)26(39-9)38-8-15-18(31)21(34)24(37)27(42-15)40-12-4-2-10(3-5-12)25-22(35)19(32)16-13(29)6-11(28)7-14(16)41-25/h2-7,9,15,17-18,20-21,23-24,26-31,33-37H,8H2,1H3/t9-,15+,17-,18+,20+,21-,23+,24+,26+,27+/m0/s1
SMILES:  C[C@H]1[C@@H]([C@H]([C@H]([C@H](OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](Oc3ccc(cc3)c3c(c(=O)c4c(cc(cc4o3)O)O)O)O2)O)O)O)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2336772
PubChem CID:   71600048
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22311 Evolvulus alsinoides Species Convolvulaceae Eukaryota n.a. whole plant n.a. PMID[17473466]
NPO22311 Evolvulus alsinoides Species Convolvulaceae Eukaryota n.a. n.a. n.a. PMID[23357036]
NPO22311 Evolvulus alsinoides Species Convolvulaceae Eukaryota n.a. n.a. n.a. PMID[24634069]
NPO22311 Evolvulus alsinoides Species Convolvulaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22311 Evolvulus alsinoides Species Convolvulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22311 Evolvulus alsinoides Species Convolvulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 239.2 ng/ml PMID[455987]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 521.4 mg/dl PMID[455987]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 105.13 mg/dl PMID[455987]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 8.47 mg kg-1 PMID[455987]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC187379 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9934 High Similarity NPC181465
0.9934 High Similarity NPC163242
0.9934 High Similarity NPC476215
0.9934 High Similarity NPC246943
0.9934 High Similarity NPC253788
0.9934 High Similarity NPC173582
0.9934 High Similarity NPC139320
0.9934 High Similarity NPC473438
0.9934 High Similarity NPC215710
0.9934 High Similarity NPC276377
0.9934 High Similarity NPC116458
0.9934 High Similarity NPC249281
0.9934 High Similarity NPC265885
0.9869 High Similarity NPC240306
0.9868 High Similarity NPC304741
0.9868 High Similarity NPC470405
0.9868 High Similarity NPC182634
0.9868 High Similarity NPC136761
0.9868 High Similarity NPC471079
0.9868 High Similarity NPC473512
0.9868 High Similarity NPC65003
0.9868 High Similarity NPC44931
0.9868 High Similarity NPC108831
0.9868 High Similarity NPC129827
0.9804 High Similarity NPC64305
0.9804 High Similarity NPC135846
0.9804 High Similarity NPC297987
0.9804 High Similarity NPC170052
0.9803 High Similarity NPC111929
0.9803 High Similarity NPC473634
0.9803 High Similarity NPC22062
0.9803 High Similarity NPC41121
0.9803 High Similarity NPC320283
0.9803 High Similarity NPC472459
0.9803 High Similarity NPC138811
0.9801 High Similarity NPC307938
0.9801 High Similarity NPC323593
0.9801 High Similarity NPC203500
0.9742 High Similarity NPC135358
0.9742 High Similarity NPC287889
0.9739 High Similarity NPC153342
0.9739 High Similarity NPC473623
0.9737 High Similarity NPC77672
0.9737 High Similarity NPC54802
0.9737 High Similarity NPC197304
0.9737 High Similarity NPC133671
0.9737 High Similarity NPC78263
0.9737 High Similarity NPC135391
0.9735 High Similarity NPC95090
0.9735 High Similarity NPC27408
0.9679 High Similarity NPC203145
0.9679 High Similarity NPC11432
0.9679 High Similarity NPC32641
0.9679 High Similarity NPC12013
0.9679 High Similarity NPC142142
0.9679 High Similarity NPC476470
0.9679 High Similarity NPC221342
0.9679 High Similarity NPC189564
0.9679 High Similarity NPC256188
0.9679 High Similarity NPC64425
0.9679 High Similarity NPC477613
0.9679 High Similarity NPC186816
0.9675 High Similarity NPC48093
0.9675 High Similarity NPC470125
0.9675 High Similarity NPC129217
0.9675 High Similarity NPC101636
0.9675 High Similarity NPC259957
0.9675 High Similarity NPC224530
0.9675 High Similarity NPC216496
0.9675 High Similarity NPC303913
0.9675 High Similarity NPC159579
0.9675 High Similarity NPC85707
0.9671 High Similarity NPC206378
0.9671 High Similarity NPC295613
0.9671 High Similarity NPC473657
0.9669 High Similarity NPC143851
0.9669 High Similarity NPC210003
0.9669 High Similarity NPC83283
0.9669 High Similarity NPC39360
0.9669 High Similarity NPC29763
0.9615 High Similarity NPC289667
0.9615 High Similarity NPC139060
0.9615 High Similarity NPC292929
0.9615 High Similarity NPC76831
0.9613 High Similarity NPC259834
0.9613 High Similarity NPC150164
0.9613 High Similarity NPC131745
0.9613 High Similarity NPC298171
0.9613 High Similarity NPC27942
0.9613 High Similarity NPC244875
0.9613 High Similarity NPC475382
0.9613 High Similarity NPC44947
0.961 High Similarity NPC142860
0.961 High Similarity NPC271270
0.961 High Similarity NPC97285
0.961 High Similarity NPC246469
0.9608 High Similarity NPC60966
0.9608 High Similarity NPC6985
0.9605 High Similarity NPC72649
0.9605 High Similarity NPC97052
0.9605 High Similarity NPC169248
0.9605 High Similarity NPC26195
0.9605 High Similarity NPC39351
0.9557 High Similarity NPC5319
0.9551 High Similarity NPC66087
0.9551 High Similarity NPC311850
0.9551 High Similarity NPC80068
0.9551 High Similarity NPC278419
0.9551 High Similarity NPC121703
0.9551 High Similarity NPC183672
0.9551 High Similarity NPC179198
0.9551 High Similarity NPC473644
0.9551 High Similarity NPC124155
0.9551 High Similarity NPC257566
0.9548 High Similarity NPC47923
0.9548 High Similarity NPC282169
0.9545 High Similarity NPC104677
0.9545 High Similarity NPC73511
0.9542 High Similarity NPC170475
0.9539 High Similarity NPC106625
0.9497 High Similarity NPC175429
0.9497 High Similarity NPC209550
0.9497 High Similarity NPC277532
0.9497 High Similarity NPC95866
0.9497 High Similarity NPC138990
0.9497 High Similarity NPC67105
0.949 High Similarity NPC205824
0.949 High Similarity NPC72016
0.949 High Similarity NPC85751
0.949 High Similarity NPC19240
0.949 High Similarity NPC129264
0.9487 High Similarity NPC190450
0.9481 High Similarity NPC313163
0.9481 High Similarity NPC161749
0.9481 High Similarity NPC197896
0.9481 High Similarity NPC258035
0.9481 High Similarity NPC122809
0.9481 High Similarity NPC156457
0.9481 High Similarity NPC288084
0.9477 High Similarity NPC99233
0.9474 High Similarity NPC121001
0.9474 High Similarity NPC88484
0.9474 High Similarity NPC259767
0.9474 High Similarity NPC259182
0.947 High Similarity NPC191154
0.9437 High Similarity NPC471725
0.9437 High Similarity NPC155877
0.9437 High Similarity NPC134532
0.9437 High Similarity NPC33054
0.9437 High Similarity NPC203259
0.9437 High Similarity NPC176740
0.9437 High Similarity NPC471748
0.9437 High Similarity NPC474522
0.9434 High Similarity NPC227508
0.943 High Similarity NPC68592
0.943 High Similarity NPC298666
0.943 High Similarity NPC115674
0.943 High Similarity NPC262222
0.943 High Similarity NPC210073
0.9423 High Similarity NPC472994
0.9423 High Similarity NPC195685
0.9423 High Similarity NPC477629
0.9423 High Similarity NPC270675
0.9423 High Similarity NPC477628
0.9423 High Similarity NPC210961
0.9419 High Similarity NPC308265
0.9416 High Similarity NPC261866
0.9416 High Similarity NPC45165
0.9416 High Similarity NPC127406
0.9408 High Similarity NPC134819
0.9375 High Similarity NPC470712
0.9375 High Similarity NPC285197
0.9375 High Similarity NPC156869
0.9375 High Similarity NPC259896
0.9375 High Similarity NPC188815
0.9375 High Similarity NPC29958
0.9375 High Similarity NPC164704
0.9375 High Similarity NPC254855
0.9375 High Similarity NPC255157
0.9375 High Similarity NPC136042
0.9375 High Similarity NPC67326
0.9371 High Similarity NPC173637
0.9371 High Similarity NPC127546
0.9371 High Similarity NPC317489
0.9371 High Similarity NPC52550
0.9371 High Similarity NPC275454
0.9371 High Similarity NPC84362
0.9371 High Similarity NPC223424
0.9367 High Similarity NPC277205
0.9363 High Similarity NPC472876
0.9359 High Similarity NPC472320
0.9359 High Similarity NPC271479
0.9359 High Similarity NPC200708
0.9355 High Similarity NPC43638
0.9355 High Similarity NPC23817
0.9342 High Similarity NPC213723
0.9338 High Similarity NPC199335
0.9321 High Similarity NPC19108
0.9321 High Similarity NPC476472
0.9321 High Similarity NPC294815

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC187379 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9557 High Similarity NPD7804 Clinical (unspecified phase)
0.9481 High Similarity NPD4381 Clinical (unspecified phase)
0.9437 High Similarity NPD6797 Phase 2
0.9379 High Similarity NPD7251 Discontinued
0.9321 High Similarity NPD7808 Phase 3
0.9313 High Similarity NPD7054 Approved
0.9255 High Similarity NPD7472 Approved
0.9136 High Similarity NPD7074 Phase 3
0.897 High Similarity NPD4338 Clinical (unspecified phase)
0.8889 High Similarity NPD6167 Clinical (unspecified phase)
0.8889 High Similarity NPD6166 Phase 2
0.8889 High Similarity NPD6168 Clinical (unspecified phase)
0.8846 High Similarity NPD4380 Phase 2
0.878 High Similarity NPD3818 Discontinued
0.875 High Similarity NPD7075 Discontinued
0.8734 High Similarity NPD6801 Discontinued
0.8654 High Similarity NPD5403 Approved
0.8645 High Similarity NPD4378 Clinical (unspecified phase)
0.8581 High Similarity NPD6799 Approved
0.8562 High Similarity NPD7096 Clinical (unspecified phase)
0.8553 High Similarity NPD1550 Clinical (unspecified phase)
0.8553 High Similarity NPD1552 Clinical (unspecified phase)
0.8526 High Similarity NPD5401 Approved
0.8509 High Similarity NPD3817 Phase 2
0.85 High Similarity NPD1934 Approved
0.8497 Intermediate Similarity NPD1549 Phase 2
0.8462 Intermediate Similarity NPD6559 Discontinued
0.8447 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD5402 Approved
0.8354 Intermediate Similarity NPD1512 Approved
0.8333 Intermediate Similarity NPD2801 Approved
0.8323 Intermediate Similarity NPD7411 Suspended
0.8291 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8261 Intermediate Similarity NPD6599 Discontinued
0.8247 Intermediate Similarity NPD2796 Approved
0.8232 Intermediate Similarity NPD3882 Suspended
0.8228 Intermediate Similarity NPD1511 Approved
0.8187 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD1510 Phase 2
0.8144 Intermediate Similarity NPD6959 Discontinued
0.8136 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8039 Intermediate Similarity NPD1240 Approved
0.8012 Intermediate Similarity NPD3751 Discontinued
0.8 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7819 Suspended
0.7988 Intermediate Similarity NPD3787 Discontinued
0.7943 Intermediate Similarity NPD8313 Approved
0.7943 Intermediate Similarity NPD8312 Approved
0.7935 Intermediate Similarity NPD1607 Approved
0.7925 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD8455 Phase 2
0.787 Intermediate Similarity NPD5494 Approved
0.7861 Intermediate Similarity NPD7584 Approved
0.7826 Intermediate Similarity NPD6780 Approved
0.7826 Intermediate Similarity NPD6777 Approved
0.7826 Intermediate Similarity NPD6779 Approved
0.7826 Intermediate Similarity NPD6782 Approved
0.7826 Intermediate Similarity NPD6781 Approved
0.7826 Intermediate Similarity NPD6778 Approved
0.7826 Intermediate Similarity NPD6776 Approved
0.7812 Intermediate Similarity NPD3750 Approved
0.7792 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD4628 Phase 3
0.7701 Intermediate Similarity NPD7698 Approved
0.7701 Intermediate Similarity NPD7696 Phase 3
0.7701 Intermediate Similarity NPD7435 Discontinued
0.7701 Intermediate Similarity NPD7697 Approved
0.7697 Intermediate Similarity NPD1653 Approved
0.7692 Intermediate Similarity NPD7768 Phase 2
0.7688 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD1551 Phase 2
0.7657 Intermediate Similarity NPD5844 Phase 1
0.7647 Intermediate Similarity NPD3749 Approved
0.764 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD7701 Phase 2
0.76 Intermediate Similarity NPD7228 Approved
0.7592 Intermediate Similarity NPD8151 Discontinued
0.7574 Intermediate Similarity NPD1465 Phase 2
0.7572 Intermediate Similarity NPD6232 Discontinued
0.7566 Intermediate Similarity NPD7870 Phase 2
0.7566 Intermediate Similarity NPD7871 Phase 2
0.7554 Intermediate Similarity NPD6534 Approved
0.7554 Intermediate Similarity NPD6535 Approved
0.755 Intermediate Similarity NPD1091 Approved
0.7543 Intermediate Similarity NPD7473 Discontinued
0.7532 Intermediate Similarity NPD1933 Approved
0.753 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD7685 Pre-registration
0.7527 Intermediate Similarity NPD7699 Phase 2
0.7527 Intermediate Similarity NPD7700 Phase 2
0.7514 Intermediate Similarity NPD7199 Phase 2
0.7513 Intermediate Similarity NPD7783 Phase 2
0.7513 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3748 Approved
0.75 Intermediate Similarity NPD7033 Discontinued
0.7486 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7461 Intermediate Similarity NPD7874 Approved
0.7461 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6798 Discontinued
0.7448 Intermediate Similarity NPD7585 Approved
0.744 Intermediate Similarity NPD7458 Discontinued
0.7436 Intermediate Similarity NPD6832 Phase 2
0.7425 Intermediate Similarity NPD920 Approved
0.7423 Intermediate Similarity NPD2800 Approved
0.7423 Intermediate Similarity NPD7801 Approved
0.7423 Intermediate Similarity NPD1652 Phase 2
0.7407 Intermediate Similarity NPD7266 Discontinued
0.7405 Intermediate Similarity NPD6233 Phase 2
0.7399 Intermediate Similarity NPD919 Approved
0.7396 Intermediate Similarity NPD7583 Approved
0.7389 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD8319 Approved
0.7382 Intermediate Similarity NPD8320 Phase 1
0.7375 Intermediate Similarity NPD6651 Approved
0.7374 Intermediate Similarity NPD5953 Discontinued
0.7368 Intermediate Similarity NPD6823 Phase 2
0.7366 Intermediate Similarity NPD4360 Phase 2
0.7366 Intermediate Similarity NPD4363 Phase 3
0.7363 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD7286 Phase 2
0.7358 Intermediate Similarity NPD1613 Approved
0.7358 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD1203 Approved
0.7346 Intermediate Similarity NPD2935 Discontinued
0.7337 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD3926 Phase 2
0.7325 Intermediate Similarity NPD4908 Phase 1
0.732 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD1243 Approved
0.7314 Intermediate Similarity NPD1247 Approved
0.7312 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD5124 Phase 1
0.731 Intermediate Similarity NPD37 Approved
0.7308 Intermediate Similarity NPD2798 Approved
0.7305 Intermediate Similarity NPD2532 Approved
0.7305 Intermediate Similarity NPD2534 Approved
0.7305 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD2533 Approved
0.7299 Intermediate Similarity NPD6234 Discontinued
0.7289 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD1548 Phase 1
0.7283 Intermediate Similarity NPD4965 Approved
0.7283 Intermediate Similarity NPD4967 Phase 2
0.7283 Intermediate Similarity NPD4966 Approved
0.7246 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD7240 Approved
0.7233 Intermediate Similarity NPD3268 Approved
0.7233 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD2313 Discontinued
0.7229 Intermediate Similarity NPD6190 Approved
0.7228 Intermediate Similarity NPD8434 Phase 2
0.7228 Intermediate Similarity NPD8150 Discontinued
0.7208 Intermediate Similarity NPD422 Phase 1
0.7205 Intermediate Similarity NPD6355 Discontinued
0.7202 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD2344 Approved
0.7179 Intermediate Similarity NPD3225 Approved
0.7178 Intermediate Similarity NPD2799 Discontinued
0.7161 Intermediate Similarity NPD9717 Approved
0.7151 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7390 Discontinued
0.7143 Intermediate Similarity NPD943 Approved
0.7135 Intermediate Similarity NPD3226 Approved
0.7134 Intermediate Similarity NPD2797 Approved
0.7134 Intermediate Similarity NPD6099 Approved
0.7134 Intermediate Similarity NPD6100 Approved
0.7128 Intermediate Similarity NPD6213 Phase 3
0.7128 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD6212 Phase 3
0.7117 Intermediate Similarity NPD7097 Phase 1
0.711 Intermediate Similarity NPD6844 Discontinued
0.7107 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD230 Phase 1
0.7097 Intermediate Similarity NPD1610 Phase 2
0.7094 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4062 Phase 3
0.7063 Intermediate Similarity NPD3027 Phase 3
0.7044 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD2354 Approved
0.7024 Intermediate Similarity NPD2309 Approved
0.7024 Intermediate Similarity NPD3887 Approved
0.7006 Intermediate Similarity NPD2654 Approved
0.7 Intermediate Similarity NPD4661 Approved
0.7 Intermediate Similarity NPD4662 Approved
0.6994 Remote Similarity NPD447 Suspended
0.6994 Remote Similarity NPD4340 Discontinued
0.6994 Remote Similarity NPD1899 Clinical (unspecified phase)
0.699 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6988 Remote Similarity NPD2346 Discontinued
0.697 Remote Similarity NPD4308 Phase 3
0.697 Remote Similarity NPD651 Clinical (unspecified phase)
0.6964 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6963 Remote Similarity NPD4361 Phase 2
0.6963 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6948 Remote Similarity NPD9545 Approved
0.6946 Remote Similarity NPD2424 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data